Population
In vitro model using cultured bovine aortic endothelial cells and radiolabeled human polymorphonuclear…
Comparison
Pretreatment with cyclooxygenase inhibitors… vs Basal conditions
Design
Preclinical
Follow-up
30 min
Authors
Loading...
Basal PMN adhesion appears COX-independent in vitro; leaves open non-COX arachidonic acid pathways as potential inflammation targets pending in vivo confirmation.
Basal PMN-endothelial adhesion in vitro is not dependent on endogenous cyclooxygenase derivatives but is reduced by agents interfering with non-cyclooxygenase-dependent arachidonic acid metabolism.
Buchanan et al. (1983) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: